Clinical Trial Update: A Non-interventional Cohort Safety Study of Patients With hATTR-PN

View source ↗

Summary

A non-interventional cohort safety study of patients with hereditary transthyretin amyloidosis with polyneuropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin Amyloidosis with Polyneuropathy

Snippet

Sponsor: Akcea Therapeutics | Conditions: Hereditary Transthyretin Amyloidosis With Polyneuropthy | Status: RECRUITING